The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project.

MLA

Elhassan, Elhussein A. E., et al. “The Utility of a Genetic Kidney Disease Clinic Employing a Broad Range of Genomic Testing Platforms: Experience of the Irish Kidney Gene Project.” Journal of Nephrology, vol. 35, no. 6, July 2022, pp. 1655–65. EBSCOhost, https://doi.org/10.1007/s40620-021-01236-2.

APA

Elhassan, E. A. E., Murray, S. L., Connaughton, D. M., Kennedy, C., Cormican, S., Cowhig, C., Stapleton, C., Little, M. A., Kidd, K., Bleyer, A. J., Živná, M., Kmoch, S., Fennelly, N. K., Doyle, B., Dorman, A., Griffin, M. D., Casserly, L., Harris, P. C., Hildebrandt, F., … Conlon, P. J. (2022). The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project. Journal of Nephrology, 35(6), 1655–1665. https://doi.org/10.1007/s40620-021-01236-2

Chicago

Elhassan, Elhussein A E, Susan L Murray, Dervla M Connaughton, Claire Kennedy, Sarah Cormican, Cliona Cowhig, Caragh Stapleton, et al. 2022. “The Utility of a Genetic Kidney Disease Clinic Employing a Broad Range of Genomic Testing Platforms: Experience of the Irish Kidney Gene Project.” Journal of Nephrology 35 (6): 1655–65. doi:10.1007/s40620-021-01236-2.